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Abstract
Background: Polycystic ovary syndrome (PCOS) is a complex disease having both genetic and environmental
components. Candidate genes with insulin metabolism have been hypothesized to be involved in the etiology of
this syndrome. In the present study, we investigated the genetic association between polymorphisms in the insulin
receptor (INSR) gene and PCOS.
Methods: A total of 260 family trios were recruited and performed a family-based analysis to assess linkage and
association between four single nucleotide polymorphisms (SNPs) (rs1799817, rs2059807, rs8108622 and
rs10500204) of INSR gene and PCOS.
Results: Using the transmission disequilibrium test (TDT), we failed to find that rs1799817 (p = 0.486), rs2059807
(p = 0.195), rs8108622 (p = 0.866) and rs10500204 (p = 1.0) were significantly overtransmitted to PCOS offspring
from their parents.
Conclusion: No significant evidence of association or linkage was found in the four tested markers, indicating that
our family samples did not support susceptibility of the INSR gene to PCOS.
Background
Polycystic ovary syndrome (PCOS), known as the most
frequently encountered endocrinopathy in women, is a
syndrome of chronic anovulatory, androgen excess and
polycystic ovaries. It affects about 5-8% of child-bearing
women[1]. This disorder is also associated with an
increased risk of hyperinsulinemia, insulin resistance,
type 2 diabetes mellitus, dyslipidemia, and cardiovascu-
lar diseases.
Previous studies have observed that PCOS is a poly-
gene inheritance disease and has strong familial cluster-
ing, suggesting that PCOS may be a genetic disease
[2-4]. Characteristics of PCOS such as elevated testos-
terone levels and polycystic ovaries have been regarded
as autosomal dominant heredity [5-7]. Over the past
decades, a number of candidate genes involved in insu-
lin signaling pathway, steroid hormone synthesis, gona-
dotropin secretion and chronic inflammation have been
performed to identify the susceptibility genes for PCOS
[8,9]. However, the mode of inheritance for PCOS and
the molecular mechanisms underlying PCOS have not
been clarified. Several factors would complicate the
molecular genetics of PCOS, such as population stratifi-
cation, environmental factors and genetic heterogeneity.
To avoid those impacting factors, it is crucial to study
family-based analysis using the transmission disequili-
brium test (TDT) to explore the putative contribution
of candidate genes.
Genes involved in insulin action have been considered
good candidates for PCOS [10,11]. Insulin resistance is
present in the majority of PCOS cases. Women with
PCOS have increased risk of type 2 diabetes [12], thus,
INSR has been suggested as a good candidate gene of
PCOS for the clinical features of PCOS. The INSR gene
is located on chromosome 19 and composed of 22
exons [13]. It plays an important role in insulin metabo-
lism. The tyrosine kinase domain mutations of the
insulin receptor have been shown to cause severe hyper-
insulinemia and insulin resistance [14-16]. In previous
studies, the polymorphism rs1799817 of INSR gene
h a sb e e np r o v e dt ob ea s s o c i a t e dw i t hP C O Si nH a n
Chinese and Caucasian [17,18]. Moreover, the SNPs
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our recent work of large scale PCOS genome-wide asso-
ciation analyses, were also suspected to be associated
with PCOS [18].
To further investigate the relationship between
rs1799817, rs2059807, rs8108622 and rs10500204 in the
INSR gene and the pathogenesis of PCOS, a family-
based analysis was performed in 260 PCOS family trios
of the present study. TDT was applied to assess linkage
and association between PCOS and the candidate gene
that may provide a better understanding of the contri-
bution of INSR gene variation in the development of
PCOS.
Methods
Subjects
Women with PCOS were recruited from the Center for
Reproductive Medicine, Provincial Hospital Affiliated
to Shandong University during the period from July
2007 to February 2010. PCOS was diagnosed according
to the 2003 Rotterdam criteria [19], i.e., at least two of
the following three features: oligomenorrhea or ame-
norrhea, clinical or biochemical hyperandrogenism
and polycystic ovaries on ultrasound. Other related
diseases, such as adrenal congenital hyperplasia, Cush-
ing syndrome, and androgen-secreting tumors were
excluded.
A total of 260 PCOS Han Chinese family trios [one
affected daughter (proband) and both parents, 780
members] were recruited for this study. Informed con-
sent for molecular studies obtained from all subjects,
the study was approved by the Ethics Committees of
Shandong University.
The mean age of 260 affected women was 27.42 years
(27.42 ± 4.02 in mean ± standard deviation (SD)) and
the mean body mass index (BMI) was 25.13 kg/m
2
(25.13 ± 4.29 in mean ± SD). The mean levels of total
testosterone were 61.25 ng/dl (61.25 ± 33.86 in mean ±
SD). Among all the probands, the mean levels of fasting
glucose and fasting insulin were 5.47 mmol/L (5.47 ±
1.31 in mean ± SD) and 11.09 mIU/L (11.09 ± 6.95 in
mean ± SD), respectively (Table 1).
Genotyping
A 5 ml whole-blood sample was collected for each sub-
ject. Genomic DNA was extracted using a QIAamp
DNA mini kit (QIAGEN, Hilden,, Germany) according
to the manufacturer’s protocol. Four valid SNPs
(rs1799817, rs2059807, rs8108622 and rs10500204) in
the INSR gene were amplified using polymerase chain
reaction (PCR) with three pairs of INSR-specific primers
(rs8108622 and rs10500204 share a pair of primers).
Positional information of the four SNPs was shown in
Table 1. The following PCR primers were used for
rs1799817: 5’ -GGTCAACGAGTCAGCCAGTCT-3’
(sense), and reverse 5’- TCCAGAAAGTGATGAGA-
CAGTGAT -3’ (antisense); for rs2059807: 5’ -G A C C -
CAGTATGCCATCTTTGTG -3’ (sense), and reverse 5’-
TGCTTGAGCCCAGGAGTTTG -3’ (antisense); and for
rs8108622 and rs10500204: 5’ - GTCCCAGATAC-
CAAGGATGTGC -3’ (sense), and reverse 5’- GAGAA
TTAGCCAAGCGAGAGTGT -3’ (antisense). The reac-
tion was carried out under the following conditions:
initial denaturation at 95°C for 5 min followed by 35
cycles of denaturation at 94°C for 30 s, annealing for 30
s at 60°C, extension at 72°C for 1 min, and finally 72°C
for 7 min. The PCR products were first analyzed by 1%
agarose gel electrophoresis (AGE) and then sequenced
on an automated sequencer (ABI PRISM 310; Applied
Biosystems, Foster City, CA).
Statistical analysis
Descriptive statistics for individual SNPs, including
minor allele frequency (MAF), Hardy-Weinberg equili-
brium as well as linkage disequilibrium (LD) statistics
between SNPs (D’,r
2) were obtained from Haploview
4.2 [20]. Then association between the four SNPs and
P C O Sw a st e s t e db yt h eT D Ta n a l y s i sw h i c hw a sp e r -
formed using Haploview 4.2 [20]. Statistical significance
was considered at the two-tailed P level of 0.05. The
TDT is a valid Chi-square test statistic for the linkage
hypothesis, regardless of population history. In the TDT
test, by collecting unrelated PCOS family trios, we
analyze the difference between the probability of par-
ents-to-offspring transmission and the hypothesis of no
association (probability of transmission 50%). If the dis-
crepancy exists, the reason would be the association
between INSR polymorphisms and PCOS.
The haplotype structure for SNPs in rs8108622 and
rs10500204 (only these two SNPs were in strong linkage
disequilibrium) was constructed and analyzed with
Haploview 4.2 [20].
Results
MAFs and TDT analysis
A total of 260 families were used for the analysis. The
MAFs of these SNPs were 0.377(rs1799817), 0.313
Table 1 Clinical and metabolic characteristics of PCOS
patients
Mean SD
Age (year) 27.42 4.02
BMI (kg/m2) 25.13 4.29
TT (ng/dl) 61.25 33.86
FG (mmol/L) 5.47 1.31
FINS (mIU/L) 11.09 6.95
SD, standard deviation; TT, Total testosterone; FG, Fasting glucose; FINS,
Fasting insulin
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respectively, and the four SNPs were in Hardy-Weinberg
equilibrium (p > 0.05) (Table 2).
TDT analysis was only performed with at least one
parent being heterozygous, so in the all 260 nuclear
families, 249 trios of rs1799817, 238 trios of rs2059807,
140 trios of rs8108622, 140 trios of rs10500204 were
entered the TDT analysis. Results from TDT were
shown in Table 3. No significant transmission disequili-
brium between the alleles of the four SNPs and PCOS
was found (rs1799817: c
2 = 0.486, p = 0.486; rs2059807:
c
2 = 1.681, p = 0.195; rs8108622: c
2 = 0.029, p = 0.866;
rs10500204: c
2 =0 ,p=1 . 0 ;s e eT a b l e3 ) .T h er e s u l t s
indicated that the four SNPs may not participate in the
pathogenesy of PCOS.
Haplotype analysis
Linkage disequilibrium was also analyzed in the subjects.
Only rs8108622 and rs10500204 were in strong LD
(r
2= 0.93, D’ = 0.965), so haplotype analysis was pursued.
However, the haplotypes did not correlate well with asso-
ciation with PCOS, as determined by TDT (Table 4).
Discussion
As a complex multigenic and heteroplasmy disease, var-
ious susceptibility genes of PCOS interact with each
other and the environmental factors also influence the
occurrence and development of the syndrome [21]. Con-
cerning molecular genetic studies, PCOS is one of the
most extensively studied endocrinopathys in women,
and attention has been given to insulin resistance, with
special focus on the INSR gene, with uncertain results.
Therefore, in this study, we used family-based analysis
in order to investigate the relationship between the
INSR gene SNPs and the genetic component of PCOS.
O u rd a t as h o w e dt h a tt h eM A F so ft h e s eS N P sw e r e
0.377(rs1799817), 0.313 (rs2059807), 0.153 (rs8108622)
and 0.153 (rs10500204), respectively, consistent with the
common population (NCBI) and our recent research
data. The MAFs in NCBI were 0.427 (rs1799817), 0.28
(rs2059807), 0.126 (rs8108622) and 0.129 (rs10500204),
respectively. And the MAFs of our recent research cases
were 0.408(rs1799817), 0.342 (rs2059807), 0.178
(rs8108622) and 0.179 (rs10500204), respectively [17,18].
Thus there was no selection bias of our subjects.
The SNP in exon 17 of the INSR gene, in the tyrosine
kinase domain of the insulin receptor have been paid
more attention. Siegel et al [22]found an association
between rs1799817 and PCOS. They argued for the first
time that the INSR gene itself took part in the develop-
ment of PCOS. Similarly, we also found the polymorph-
ism itself may predispose to the development of PCOS
[17]. In India, the researchers found an association of
rs1799817 with indices of insulin resistance and hyper-
androgenemia in the same subgroup [21]. Not corrobor-
ating previous studies, we failed to find that rs1799817,
rs2059807, rs8108622 and rs10500204 were significantly
over-transmitted to PCOS offspring from their parents
by using a genetic approach of association analysis.
Moreover, the analysis of the haplotypes did not show
evidence of association between these polymorphisms
and PCOS. The results of the analysis of individual
alleles, as well as the analysis of haplotypes, appeared
to exclude a direct role of rs1799817 in exon 17,
rs2059807 in intron 8, rs8108622 and rs10500204 in
intron 3 at the INSR gene in the pathogenesis of PCOS
in our sample. As well as a case-control association
study carried out in Korean population, they also failed
to provide evidence for the association between INSR
gene and PCOS [12].
The discrepancy between these studies may be caused
by population stratification. Considering using the clas-
sic case-control design would have the limitation that
associations between allelic variants in candidate genes
and disease might have arisen on account of population
stratification by ethnicity or environmental factors [23],
a family-based association study (case-parent trios) was
used in the present research rather than unrelated cases
and controls (case-control study). Using the TDT analy-
sis, a particularly appropriate test for a possible role of a
Table 2 Positional Information and summary statistics for
SNPs in the INSR gene
Variant Location Position
a Alleles
b HWE p MAF
rs1799817 Exon 17 197125297 C/T 0.957 0.377
rs2059807 Intron 8 197166109 T/C 0.193 0.313
rs8108622 Intron 3 197182753 T/A 0.480 0.153
rs10500204 Intron 3 197182963 A/C 0.480 0.153
a Contig accession number is NT_011255.14;
b Minor allele in bold
MAF, Minor allele frequency
Table 3 TDT results for the four SNPs in INSR gene
Marker ID Overtransmitted allele T Not-T Total TDT Transmission frequency TDT c
2 P-value
rs1799817 C 130 119 249 0.522 0.486 0.486
rs2059807 C 129 109 238 0.542 1.681 0.195
rs8108622 T 71 69 140 0.507 0.029 0.866
rs10500204 - 70 70 140 0.500 0 1.0
T, number of transmissions in TDT analysis
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we can get rid of the influence of population stratifica-
tion. The result indicated that these polymorphisms at
the INSR gene were unlikely to be relevant in the devel-
opment of PCOS in our sample.
In addition, as environmental factors are also involved
in PCOS [24,25], the interaction with gene may be a key
point of the pathogenesis in PCOS, not only the gene
itself. When we used the family trios analyzing the sub-
jects’ genotypes, the interaction would be exorcized. So
that may be one reason for we did not find any associa-
tion between the four SNPs and PCOS.
Our results also showed that the MAFs of both of
rs8108622 and rs10500204 were only 15.3%, therefore,
the number of families that could be analyzed using
TDT was small (only 140). Thus, we speculated that
negative result of our association study of INSR gene
with PCOS might due to the low frequency of the two
SNPs in Chinese Han population. And a larger scale
family-based research should be carried out to identify
the role of the SNPs in PCOS. Furthermore, because of
the highly polymorphic of INSR molecule, further inves-
tigations are needed to address the contribution of other
SNPs and several polymorphisms in the form of haplo-
types [26]. There is the possibility that molecular defects
in other genes that regulate the expression of the INSR
gene could be involved in the pathogenesis of PCOS.
Our study covered a relatively large series of PCOS
trios and represents the first family association study
providing data about the INSR gene and PCOS in a Chi-
nese Han population. Finally, we have to mention that
PCOS is a multi-factorial disease, even though our data
showed no evidence that INSR gene polymorphism
increases the risk of developing the syndrome, further
investigations with an increased number of subjects and
more SNPs are necessary.
Conclusions
In the present study the relationship between the INSR
gene SNPs and the pathogenesis of PCOS was investi-
gated in 260 PCOS family trios. Using the transmission
disequilibrium test, we failed to find that rs1799817,
rs2059807, rs8108622 and rs10500204 were significantly
over-transmitted to PCOS offspring from their parents.
Our family based research did not support susceptibility
of the INSR gene to PCOS and further investigations
with an increased number of subjects and more SNPs
are necessary.
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